Accuracy of ultrasonography in the assessment of liver fat compared with MRI
- PMID: 30955836
- DOI: 10.1016/j.crad.2019.02.014
Accuracy of ultrasonography in the assessment of liver fat compared with MRI
Abstract
Aim: To investigate the accuracy of ultrasonography in the assessment of hepatic steatosis using magnetic resonance imaging (MRI) as standard of reference and to explore the influence of additional hepatic iron overload.
Material and methods: A total of 2,783 volunteers (1,442 women, 1,341 men; mean age, 52.3±13.8 years) underwent confounder-corrected chemical-shift-encoded MRI of the liver at 1.5 T. Proton-density fat fraction (PDFF) and transverse relaxation rate (R2*) were calculated to estimate hepatic steatosis and liver iron overload, respectively. In addition, the presence of hepatic steatosis was assessed by B-mode ultrasonography. The sensitivity, specificity, and accuracy of hepatic ultrasonography were determined for different degrees of hepatic steatosis and different amounts of liver iron.
Results: MRI revealed hepatic steatosis in 40% of participants (n=1,112), which was mild in 68.9% (n=766), moderate in 26.7% (n=297), and severe in 4.4% (n=49) of patients. Ultrasonography detected hepatic steatosis in 37.8% (n=1,052), corresponding to 74.5% sensitivity and 86.6% specificity. The sensitivity of ultrasound increased with the amount of hepatic fat present and was 65.1%, 95%, and 96% for low, moderate, and high fat content; whereas the specificity was constantly high at 86.6%. The diagnostic accuracy of ultrasound for detection of hepatic steatosis did not vary significantly with the amount of liver iron present.
Conclusion: Ultrasonography is an excellent tool to assess hepatic steatosis in the clinical setting with some limitations in patients with a low liver fat content. The detection of hepatic steatosis by ultrasonography is not influenced by liver iron.
Copyright © 2019. Published by Elsevier Ltd.
Similar articles
-
Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.Ultrasound Med Biol. 2019 Jun;45(6):1407-1416. doi: 10.1016/j.ultrasmedbio.2019.02.008. Epub 2019 Apr 8. Ultrasound Med Biol. 2019. PMID: 30975533
-
Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?Liver Transpl. 2018 Apr;24(4):470-477. doi: 10.1002/lt.24965. Epub 2018 Mar 6. Liver Transpl. 2018. PMID: 29080242
-
Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.Abdom Radiol (NY). 2019 Sep;44(9):3040-3048. doi: 10.1007/s00261-019-02118-9. Abdom Radiol (NY). 2019. PMID: 31286208
-
Fat Quantification in the Abdomen.Top Magn Reson Imaging. 2017 Dec;26(6):221-227. doi: 10.1097/RMR.0000000000000141. Top Magn Reson Imaging. 2017. PMID: 29176468 Free PMC article. Review.
-
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.J Hepatol. 2009 Sep;51(3):433-45. doi: 10.1016/j.jhep.2009.05.023. Epub 2009 Jun 11. J Hepatol. 2009. PMID: 19604596 Review.
Cited by
-
Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults.Front Endocrinol (Lausanne). 2022 Sep 16;13:1004855. doi: 10.3389/fendo.2022.1004855. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36187093 Free PMC article.
-
Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease.World J Gastroenterol. 2022 Sep 28;28(36):5364-5379. doi: 10.3748/wjg.v28.i36.5364. World J Gastroenterol. 2022. PMID: 36185625 Free PMC article.
-
Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD.Front Pharmacol. 2022 Aug 30;13:905126. doi: 10.3389/fphar.2022.905126. eCollection 2022. Front Pharmacol. 2022. PMID: 36110512 Free PMC article.
-
Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review.Visc Med. 2022 Apr;38(2):126-132. doi: 10.1159/000519611. Epub 2021 Oct 26. Visc Med. 2022. PMID: 35614896 Free PMC article. Review.
-
SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2022 Mar 27;23(7):3668. doi: 10.3390/ijms23073668. Int J Mol Sci. 2022. PMID: 35409028 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
